Recent News

• 01.30.2026 - Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update
• 01.21.2026 - Alterity Therapeutics Issues Shareholder Letter Highlighting 2025 Progress and Key Objectives for 2026

Recent Filings

• 01.21.2026 - EX-99.1 EX-99.1
• 01.21.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 01.15.2026 - EX-99.1 EX-99.1
• 01.15.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 01.15.2026 - EX-99.1 EX-99.1
• 01.15.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 01.13.2026 - EX-99.1 EX-99.1
• 01.13.2026 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 01.07.2026 - EX-99.1 EX-99.1
• 01.07.2026 - EX-99.1 EX-99.1